A patient at an Indian leprosy hospital
EPA/FAROOQ KHAN
The Swiss Tropical and Public Health Institute (Swiss TPH) has helped create an international partnership of several leading leprosy groups. Sunday is World Leprosy Day.
Supported by the World Health Organization (WHO), the new Global Partnership for Zero LeprosyExternal link brings together organizations like the Swiss-based Novartis Foundation, the International Federation of Anti-Leprosy Associations (ILEP), the International Association for Integration, Dignity and Economic Advancement (IDEA), national leprosy programmes and academic institutions.
Peter Steinmann of Swiss TPH represents the scientific community in the creation of this partnership.
“Swiss TPH is actively involved in establishing the proof-of-concept of novel interventions against leprosy,” said Steinmann in a media releaseExternal link. “The new partnership offers a unique platform to harness the results of the best science for the benefit of the world’s poorest people.”
The Global Partnership for Zero Leprosy will coordinate action in three key areas: 1) diagnostic research and therapeutic tools to prevent spread of leprosy; 2) technical assistance and expertise to strengthen existing national programmes and accelerate translation of new evidence; and (3) advocacy and fundraising.
Despite the availability of effective multi-drug therapy, the number of newly diagnosed leprosy patients has remained above 200,000 per year for the last decade, including thousands of children, according to Swiss TPH. The institute blames inadequate resources and stigma.
Popular Stories
More
Foreign Affairs
Swiss defence industry moving abroad to escape neutrality
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
This content was published on
The bise, a cold dry wind, played havoc with air traffic at Zurich Airport on Friday. Numerous flights were delayed and some were cancelled.
UBS reportedly in talks to sell hedge fund O’Connor
This content was published on
UBS is in talks to sell O'Connor, one of its hedge fund units (high-risk funds), to the US firm Cantor Fitzgerald, according to Bloomberg.
Six anti-LGBTQ+ hate crimes reported a week in Switzerland
This content was published on
On average, almost six hate crimes are reported a week against LGBTQ+ people in Switzerland. Last year there were 309 cases.
Swiss authorities profit from unexchanged banknotes
This content was published on
The Swiss government and cantons will receive over CHF700 million from the Swiss National Bank because old banknotes worth almost CHF1 billion have not been exchanged.
This content was published on
The legal distribution of cannabis can reduce problematic consumption, particularly among people who also use other drugs, according to a study from Basel.
Banks increasingly active in use of artificial intelligence
This content was published on
Having overcome initial reticence, more and more retail banks are turning to artificial intelligence (AI) to optimise processes and offer new products.
This content was published on
During the collision of lead nuclei at almost the speed of light, the conversion of lead into gold was measured using a new mechanism.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Most British red squirrels ‘have leprosy’
This content was published on
The disease, which was prevalent in the Middle Ages, has long been wiped out in humans in Britain. But it appears that red squirrels are still highly susceptible to the two types of bacteria, resulting in swelling and hair loss to the ears, muzzle and feet. Researchers from Lausanne’s Federal Institute of Technology (EPFL) joined…
This content was published on
The team used advanced DNA analysis and field work to confirm the link to armadillos, the only other known carriers of the disease. The study was published in the New England Journal of Medicine on Thursday. While there are only around 150 cases of leprosy in the US annually, most victims have worked abroad in…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.